Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India

• DOI: 10.1016/j.transci.2020.103025
• Publication Date: 2020-11-26T17:45:38Z
• Authors: Jayastu Senapati; Mukul Aggarwal; Liji Louis; Saleem A. Mirza; Pradeep Kumar; Rishi Dhawan; Jasmita Dass; Ganesh K. Vishwan...; Hem Chandra Pandey; Poonam Coshic; Seema Tyagi; Tulika Seth; Manoranjan Mahapatra
• Keywords: Adult; Aged, 80 and over; Male; Adolescent; Platelet-Rich Plasma; SARS-CoV-2; COVID-19; India; Infant; Blood Component Transfusion; Hematology; Middle Aged; Article; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Child, Preschool; Humans; Female; Child; Pandemics; Aged; Retrospective Studies

The Coronavirus disease-19 (COVID-19) pandemic has in multiple ways affected healthcare delivery to non-COVID patients throughout the world. Adequate transfusion services are fundamental in ongoing therapy of patients with hematological ailments. We present the transfusion services in the hematology daycare under the department of Hematology and supported by the Blood Bank at our institution for the period 12th April 2020-30th June 2020, which saw the stringent lockdown and unlocking Phase I in India, declared in lieu of the pandemic. A 56 % reduction in total transfusion sessions was observed in 2020 (588 sessions given to 176 patients) compared to 1336 sessions in 516 patients over the same period in 2019. The reductions were seen across the different blood components (packed red blood cells [PRBC]: 585 vs. 1840, platelet rich plasma: 372 vs. 1313, single donor platelet 18 vs. 16), with a significant reduction in the mean PRBC transfused per PRBC transfusion session (1.11 vs 1.99, p<0.001) in 2020, compared to 2019. There were however no major differences in the transfusion practices across the different phases of the lockdown. Our study highlights the detrimental reduction in transfusion services due to the COVID-19 pandemic and related lockdown and showcases the remedial strategies taken to maximize transfusion support to patients during this period. Our observations might help to provide insights to adequately combat possible similar adverse situations in the future.